ERRα plays a key role in energy homeostasis and will probably be targeted for the treatment of metabolic disorders, which controls the expression of genes involved in the glycolytic pathway, TCA cycle and OXPHOS31,32. The gene discussed is ESRRA; the disease is Other metabolic disease.